These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7285479)

  • 1. Effect of food on lidocaine kinetics: mechanism of food-related alteration in high intrinsic clearance drug elimination.
    Elvin AT; Cole AF; Pieper JA; Rolbin SH; Lalka D
    Clin Pharmacol Ther; 1981 Oct; 30(4):455-60. PubMed ID: 7285479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Food effects on propranolol systemic and oral clearance: support for a blood flow hypothesis.
    Olanoff LS; Walle T; Cowart TD; Walle UK; Oexmann MJ; Conradi EC
    Clin Pharmacol Ther; 1986 Oct; 40(4):408-14. PubMed ID: 3757404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of route of administration and blood flow on hepatic drug elimination.
    Shand DG; Kornhauser DM; Wilkinson GR
    J Pharmacol Exp Ther; 1975 Dec; 195(3):424-32. PubMed ID: 1195129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased toxicity and reduced clearance of lidocaine by cimetidine.
    Feely J; Wilkinson GR; McAllister CB; Wood AJ
    Ann Intern Med; 1982 May; 96(5):592-4. PubMed ID: 7073151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic drug clearance following traumatic injury.
    Slaughter RL; Hassett JM
    Drug Intell Clin Pharm; 1985 Nov; 19(11):799-806. PubMed ID: 3905320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discussions on the hepatic well-stirred model: Re-derivation from the dispersion model and re-analysis of the lidocaine data.
    Dong J; Park MS
    Eur J Pharm Sci; 2018 Nov; 124():46-60. PubMed ID: 30102979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of viral hepatitis on the disposition of two compounds with high hepatic clearance: lidocaine and indocyanine green.
    Williams RL; Blaschke TF; Meffin PJ; Melmon KL; Rowland M
    Clin Pharmacol Ther; 1976 Sep; 20(3):290-9. PubMed ID: 954351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of smoking and chronic hepatitis B on lidocaine and indocyanine green kinetics.
    Huet PM; Lelorier J
    Clin Pharmacol Ther; 1980 Aug; 28(2):208-15. PubMed ID: 7398188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lidocaine kinetics predicted by indocyanine green clearance.
    Zito RA; Reid PR
    N Engl J Med; 1978 May; 298(21):1160-3. PubMed ID: 651945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lidocaine disposition--sex differences and effects of cimetidine.
    Wing LM; Miners JO; Birkett DJ; Foenander T; Lillywhite K; Wanwimolruk S
    Clin Pharmacol Ther; 1984 May; 35(5):695-701. PubMed ID: 6713782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nadolol and propranolol on plasma lidocaine clearance.
    Schneck DW; Luderer JR; Davis D; Vary J
    Clin Pharmacol Ther; 1984 Nov; 36(5):584-7. PubMed ID: 6488678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hypoxia on the hepatic metabolism of lidocaine in the isolated perfused pig liver.
    Mets B; Hickman R; Allin R; Van Dyk J; Lotz Z
    Hepatology; 1993 Apr; 17(4):668-76. PubMed ID: 8477972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new model-independent physiological approach to study hepatic drug clearance and its applications.
    Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):577-90. PubMed ID: 6389376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of SKF-525A and of altered hepatic blood flow on lidocaine clearance in the cat.
    Lautt WW; Skelton FS
    Can J Physiol Pharmacol; 1977 Feb; 55(1):7-12. PubMed ID: 843992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of antipyrine, acetaminophen and lidocaine in fed and fasted horses.
    Engelking LR; Blyden GT; Lofstedt J; Greenblatt DJ
    J Vet Pharmacol Ther; 1987 Mar; 10(1):73-82. PubMed ID: 3586126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic and renal clearances of lidocaine in conscious and anesthetized sheep.
    Mather LE; Runciman WB; Carapetis RJ; Ilsley AH; Upton RN
    Anesth Analg; 1986 Sep; 65(9):943-9. PubMed ID: 3740492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of drug disposition in patients with cirrhosis.
    Huet PM; Villeneuve JP
    Hepatology; 1983; 3(6):913-8. PubMed ID: 6629320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of food on hepatic blood flow: implications in the "food effect" phenomenon.
    Svensson CK; Edwards DJ; Mauriello PM; Barde SH; Foster AC; Lanc RA; Middleton E; Lalka D
    Clin Pharmacol Ther; 1983 Sep; 34(3):316-23. PubMed ID: 6883907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of beta-adrenoceptor antagonists on the pharmacokinetics of lignocaine.
    Tucker GT; Bax ND; Lennard MS; Al-Asady S; Bharaj HS; Woods HF
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):21S-28S. PubMed ID: 6146336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.